欧洲人类生殖与胚胎学学会定义的复发性种植失败的危险因素
该队列研究基于2019年6月至2022年6月中山大学附属第一医院生殖医学中心15329个辅助生殖技术周期,纳入298例复发性种植失败(RIF)患者和2056例对照,采用随机森林模型分析32个变量。结果显示抗苗勒管激素(AMH)是RIF最强预测因子,其次为慢性子宫内膜炎、宫腔粘连和BMI;模型在训练集AUC为0.83(95%CI:0.80-0.86),测试集为0.78(95%CI:0.73-0.84)。
要点
- AMH是RIF最强预测因子,慢性子宫内膜炎、宫腔粘连和BMI分列第二至第四位。
- 随机森林模型预测RIF的训练集AUC为0.83(95%CI:0.80-0.86),测试集为0.78(95%CI:0.73-0.84)。
- 除年龄外,AMH等高风险因素也应纳入RIF的考量。
核心结论
- AMH是RIF最强预测因子,其次为慢性子宫内膜炎、宫腔粘连和BMI。
研究设计与样本
- 队列研究,纳入2019年6月至2022年6月中山大学附属第一医院生殖医学中心15329个ART周期中的298例RIF患者和2056例对照。
- 对照为在1-2个移植周期内成功种植胚胎的女性。
- RIF依据ESHRE 2023推荐定义,采用随机森林构建机器学习预测模型,以AUC和校准图评估预测准确性,并用SHAP框架解释模型。
主要发现
- 从32个变量中,随机森林模型显示高AMH水平和高活产次数与RIF风险降低相关。
- 慢性子宫内膜炎、宫腔粘连、高FSH水平、高睾酮水平、高龄、息肉、复发性流产史、剖宫产史、多囊卵巢综合征和风湿性疾病与RIF风险升高相关。
- 预测模型训练集AUC为0.83(95%CI:0.80-0.86),测试集AUC为0.78(95%CI:0.73-0.84)。
- 校准曲线显示训练集和测试集均具有良好的预测性能。
- SHAP值显示AMH对RIF风险影响最大,慢性子宫内膜炎、宫腔粘连和BMI分别为第二、第三和第四位显著预测因素。
临床怎么用
- 作者认为,除年龄外,某些高风险因素如AMH也应纳入RIF的考量。
- 作者指出,合并这些高风险因素的患者可能需要更多尝试才能获得成功妊娠。
局限性
- 本研究为回顾性设计,来自单一生殖医学中心。
- 部分疾病如息肉、黏膜下肌瘤和风湿性疾病在ART前已接受治疗,提示这些因素在治疗后仍影响RIF。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: What are the unrecognized risk factors for recurrent implantation failure (RIF) as defined in the ESHRE recommendation? SUMMARY ANSWER: Anti-Müllerian hormone (AMH) is the strongest predictor for RIF, followed by chronic endometritis (CE), intrauterine adhesions, and BMI. WHAT IS KNOWN ALREADY: Advanced age is a well-known risk factor for implantation failure, and the definition of RIF was stratified by age in the 2023 ESHRE recommendation. However, the literature identifies other risk factors, including CE, endometriosis, BMI, endometrial polyps, intrauterine adhesions, hydrosalpinx, uterine malformation, submucosal myoma, polycystic ovary syndrome, thyroid dysfunction, rheumatic diseases, and hyperprolactinemia, to be associated with implantation failure. In addition, our clinical experience suggests AMH and a history of previous livebirth affect RIF. It remains unclear which of these factors are the best predictors of RIF. STUDY DESIGN, SIZE, DURATION: A cohort study drawn from ART cycles between June 2019 and June 2022. PARTICIPANTS/MATERIALS, SETTING, METHODS: Two hundred and ninety-eight RIF patients and 2056 controls (women who achieved successful embryo implantation within 1-2 transfer cycles) were identified from 15 329 ART cycles at the Reproductive Medical Center at the First Affiliated Hospital of Sun Yat-sen University. RIF was defined according to the recommendation of ESHRE 2023. Basic characteristics, reproductive history, laboratory indicators (autoantibodies and endocrine factors), ultrasound, laparoscopy, hysteroscopy, hysterosalpingography, biopsy, and immunohistochemistry results were collected from the electronic medical record system. The Random Forest procedure was applied to build a machine learning model for predicting RIF. Overall predictive accuracy was assessed by using the AUC of receiver-operator characteristic curve and calibration plots. The SHapley Additive exPlanations (SHAP) framework was used to interpret the model. MAIN RESULTS AND THE ROLE OF CHANCE: From 32 variables, elevated AMH level and greater number of live births were associated with lower risk of RIF, while CE, intrauterine adhesions, high FSH level, high testosterone level, advanced female age, polyps, history of recurrent pregnancy loss, history of cesarean section, polycystic ovary syndrome, and rheumatic diseases were associated with higher risk of RIF according to the established random forest model. The predictive model yielded AUCs of 0.83 (95% CI: 0.80-0.86) in training dataset and 0.78 (95% CI: 0.73-0.84) in testing dataset. The calibration curve indicated good predictive performance in both training and testing datasets. SHAP values indicated that AMH had the greatest influence on the RIF risks, whereas CE, intrauterine adhesions, and BMI were the second, third, and fourth most significant risk factors for predicting RIF, respectively. LIMITATIONS, REASONS FOR CAUTION: This research was limited by its retrospective design from a single reproductive medical center. Moreover, some diseases, such as polyps, submucosal myomas, and rheumatic diseases, had been treated before ART, which indicates that these factors impact RIF even after treatment. WIDER IMPLICATIONS OF THE FINDINGS: In addition to age, certain high-risk factors, such as AMH, should also be included in the considerations for RIF. Patients with a combination of these high-risk factors may require more attempts to achieve a successful pregnancy. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the Guangzhou Municipal Science and Technology Project under Grant (202206010003) and the National Natural Science Foundation of China under Grant (81871159). None of the authors has any conflict of interest. TRIAL REGISTRATION NUMBER: N/A.
引用
- Wang C, Lu Y, Ou M, et al. Risk factors for recurrent implantation failure as defined by the European Society for Human Reproduction and Embryology. Hum Reprod. 2025. PMID: 40143620. doi:10.1093/humrep/deaf042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。